Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

11.53
Delayed Data
As of 4:00pm ET
 -0.10 / -0.86%
Today’s Change
6.96
Today|||52-Week Range
17.78
-33.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues42.3M54.8M75.3M135.1M
 
 
 
 
 
Cost of Goods Sold1.1M5.0M21.0M27.6M
 
 
 
 
 
Depreciation And Amortization1.1M1.2M1.8M1.7M
 
 
 
 
 
 
Operating ExpensesGross Income40.2M48.6M52.6M105.8M
 
 
 
 
 
General Expenses93.8M129.0M114.2M133.3M
 
 
 
 
 
Research And Development69.0M96.6M78.6M93.2M
 
 
 
 
 
Total Operating Expenses96.0M135.2M137.0M162.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-53.6M-80.4M-61.6M-27.5M
 
 
 
 
 
Extraordinary Charge0.000.00-1.4M0.00
 
 
Interest Expense On Debt--3.3M5.6M5.2M
 
 
 
 
Other Expenses14.4K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.6M-83.5M-68.4M-32.2M
 
 
 
 
 
Net Income-53.6M-83.5M-68.4M-32.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS111.1M112.8M122.7M126.7M
 
 
 
 
 
Shares To Calculate EPS Diluted111.1M112.8M122.7M126.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$0.74-$0.56-$0.25
 
 
 
 
 
EPS Diluted-$0.48-$0.74-$0.56-$0.25